Memorial Sloan-Kettering Cancer

New York, New York 10065

0 studies enrolling now · 5 studies all time

What they study most

Advanced Malignancies, Brain Cancer, Breast Cancer, Cancer, Glioblastoma, Metastatic Cancer

Studies at this site

• A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma — Running, not enrolling
• Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer — Running, not enrolling
• Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies — Completed
• Pembrolizumab +/- Bevacizumab for Recurrent GBM — Completed
• Validation Study of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) — Completed